[Therapeutic effect of pelvic methotrexate injection via the posterior fornix for treatment of tubal pregnancy].
Nan Fang Yi Ke Da Xue Xue Bao
; 31(2): 377-9, 2011 Feb.
Article
em Zh
| MEDLINE
| ID: mdl-21354935
ABSTRACT
OBJECTIVE:
To evaluate the therapeutic effect and safety of pelvic methotrexate (MTX) injection via the posterior fornix for treatment of tubal pregnancy.METHODS:
Ninety-six patients with tubal pregnancy (mean age 21-40 years) were randomized into 3 groups for treatment with pelvic MTX injection via the posterior fornix+mifepristone+traditional Chinese medicine (experiment group), intramuscular MTX injection+mifepristone+traditional Chinese medicine (control group I), or mifepristone+traditional Chinese medicine (control group II). On days 4 and 7 of the treatment, blood ß-HCG of the patients in different groups was detected, and in cases with continuous reduction of blood ß-HCG or a reduction by over 15%, ß-HCG was checked every week. One week after the treatment, the size of the mass was measured by B-mode ultrasound. The clearance time of ß-HCG and the hospital stay of the patients were recorded.RESULTS:
Twenty-nine patients in the experimental group were treated successfully, with a cure rate of 90.6%, which was significantly higher than those in the two control groups (P<0.05). The clearance time of ß-HCG and hospital stay were also much shorter in the experimental group (P<0.05).CONCLUSION:
Pelvic MTX injection via the posterior fornix is a convenient procedure associated with minimal complications and serves as a good alternative for treatment of tubal pregnancy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Gravidez Tubária
/
Vagina
/
Abortivos não Esteroides
/
Metotrexato
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
Zh
Revista:
Nan Fang Yi Ke Da Xue Xue Bao
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
China